Bioavailability file: Teicoplanin;Biyoyararlanim dosyasi: Teikoplanin

Fabad Journal of Pharmaceutical Sciences

Volumn 26, Issue 3, 2001, Pages 143-155

  Yenice, Irem ^a   Çaliş, Sema ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bioavailability; Glycopeptide antibiotic; Pharmacokinetic; Teicoplanin

Indexed keywords

ANTIBIOTIC AGENT; GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

BACTEREMIA; BACTERIAL ENDOCARDITIS; BONE INFECTION; CATHETER INFECTION; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; INFECTIOUS ARTHRITIS; PHYSICAL CHEMISTRY; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION;

EID: 0035739304     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Teicoplanin: Chemical, physico-chemical and biological aspects
2. Teichomycins; new antibiotics from actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization
3. Teichomycins, new antibiotics from actinoplanes teichomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties
4. Teicoplanin, a new antibiotic from actinoplanes teichomyceticus nov. sp
5. Structure, biochemistry and mechanism of action of glycopeptide antibiotics
6. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycopeptide antibiotics
7. Thermodynamic analysis of the interaction of the antibiotic teicoplanin and is aglycone with cell-wall peptides
8. In vitro activity of teichomycin against isolates of gram-positive bacteria
9. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections
10. Teicoplanin, vancomycin, rifampicin: In-vivo and in-vitro studies with Staphlococcus aureus
11. Microbiological properties of teicoplanin
12. Treatment of bone, joint, and vascularaccess-associated gram-positive bacterial infections with teicoplanin
13. Treatment of bone and soft tissue infections with teicoplanin
14. Teicoplanin in the treatment of skin and soft tissue infections
15. Teicoplanin in emprical combined antibiotic therapy of bacteremias in bone marrow
16. Clinical efficacy and safety of teicoplanin
17. Multicentre open clinical trial of teicoplanin in infections caused by grampositive bacteria
18. Teicoplanin
19. Clinical pharmacokinetics of teicoplanin
20. Pharmacokinetics of individual components of teicoplanin in man
21. Teichomycin: In-vitro and in-vivo evaluation in comparison with other antibiotics
22. Comparison and modeling study of vancomycin, ristocetin-A, and teicoplanin for CE enantioseparations
23. Structure and mechanism of action of teicoplanin
24. Binding of teicoplanin and vancomycin to polymer surfaces
25. Bioassay for teicoplanin in peritoneal dialysis fluid
26. High-performance liquid chromatographic determination of teichoplanin in plasma: Comparison with a microbiological assay
27. Teicoplanin measurement in patients with renal failure: Comparison of fluorescence polarization immunoassay, microbiological assay, and high performance liquid chromatographic assay
28. Teicoplanin a glycopeptide antibiotic: Stability and microbiological evaluation
29. Assay of serum teicoplanin concentrations in clinical specimens: A comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay
30. Solid-phase enzyme-receptor assay (SPERA): A competitive-binding assay for glycopeptide antibiotics of the vancomycin class
31. A receptor antibody sandwich assay for teicoplanin
32. Performance of a fluorescence polarization immunoassay for teicoplanin in serum
33. Evaluation of a novel fluorescence polarization immunoassay for teicoplanin
34. Performance of a fluorescence polarization immunoassay for teicoplanin in serum
35. Identification of fluorescent glycopeptide derivatives by two consecutive high pressure liquid chromatographic procedures
36. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high performance liquid chromatography
37. HPLC quantitation of the six main components of teicoplanin in biological fluids
38. Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers
39. The pharmacokinetics of teicoplanin in infants and children
40. Pharmacokinetics of teicoplanin
41. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
42. Stability and compatibility of teicoplanin in parenteral nutrition solutions used in pediatrics
43. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin
44. Coagulase-negative staphlococci emerging during teicoplanin therapy and problems in determination of their sensitivity
45. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and clostridium difficile
46. Susceptibility of penicillin-sensitive and- resistant strains of Streptococcus pneumaniae to new anti-microbial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones
47. Comparison of the modified Stokes method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints
48. Susceptibility of staphylococcus species and subspecies to teicoplanin
49. Glikopeptid antibiyotikler: Vankomisin ve teikoplanin
50. Teicoplanin; a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential
51. Teicoplanin; a reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy
52. Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers
53. In vitro elution of vancomycin from biodegradable beads
54. Incorporation and release of vancomycin from poly,D,L-lactide-co glycolide) microspheres
55. Ortopedide kullanilan biyoparçalanabilir polimerler ile hazirlanan teikoplanin içeren mikropartiküler sistemli implantlarin formülasyonu ve in vitro/in vivo deǧerlendirilmesi üzerine çalişmalar
56. Teicoplanin (a glycopeptide antibiotic) loaded biodegradable microparticulate system: Formulation considerations and in vitro evaluation
57. In vitro studies of teicoplanin binding to rat tissues and erythrocytes
58. Theicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing
59. Pharmacokinetics of teicoplanin in children
60. Pharmacokinetics of teicoplanin in renal failure
61. Teicoplanin metabolism in humans